RxDoctor Payments Data

Casey Kasisky

Medical · Moosic, PANPI 1699251728

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 99.4% of the total across 1,154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 35 manufacturers, the largest accounting for just 11.3% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$24,084in general payments, 2019–2025

Across 1,154 payments — averaging $20.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Teva Pharmaceuticals USA, Inc.$3K
  • Johnson & Johnson$3K
  • AbbVie$2K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$2K
  • Neurocrine Biosciences, Inc.$2K
  • Otsuka America Pharmaceutical, Inc.$2K
  • plus $11K from 29 others

What the payments were for

  • Food & beverage$23,93799%
  • Education$1471%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$24,084 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
Austedo XrDeutetrabenazine15$187,044
VraylarCariprazine Hcl21$37,243
TrintellixVortioxetine Hydrobromide13$7,911
Lurasidone Hcl27$4,111
Desvenlafaxine Succinate ErDesvenlafaxine Succinate72$2,952
Bupropion XlBupropion Hcl76$1,526
Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine34$1,166
Venlafaxine Hcl ErVenlafaxine Hcl62$1,144
Duloxetine Hcl57$977
Divalproex Sodium ErDivalproex Sodium22$961
Buspirone Hcl73$936
Escitalopram Oxalate66$866
Vilazodone Hcl13$803
Sertraline Hcl52$577
Lamotrigine48$501

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo Xr$2,726$187,04415 claims
AbbVieVraylar$2,095$37,24321 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$1,227$7,91113 claims
Almatica Pharma LLCSertraline Hcl$117$57752 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Moosic

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →